Orlistat is recommended as an adjunct to diet and exercise for weight loss in people with type 2 diabetes mellitus (T2DM) or prediabetes. However, the extent ... prediabetes in real world settings were lacking. We…
adherence of General practitioners (GPs) to national guidelines for the prescription and monitoring of Orlistat (Xenical). Methods: All patients currently taking Orlistat for weight-loss at one General Practice…
Background: The study was to determine the effect of orlistat drug and green coffee in the body weight and lipid profiles in hypercholesterolemia rats. Methods: Forty male albino rats with ... three rats fed with high…
Context: Orlistat is one of the few anti-obesity drugs that have been approved by FDA. It reduces the lipid absorption by 30% in its therapeutic dose by means ... three groups. For the purpose of testing our hypothesis…
Approximately a decade has pasted since the introduction of orlistat for the treatment of obesity. A considerable amount of clinical trial evidence has been accumulated to demonstrate that orlistat ... either in…
Orlistat 120 mg was approved as a prescription product by the FDA in 1999 for obesity management, Orlistat was purchased as a capsule with a trade name (Xenical) manufactured ... Germany. This study will be conducted to…
Orlistat is a selective inhibitor of gastric and pancreatic lipase indicated for the treatment of obesity. It is also known to significantly reduce risk of associated co-morbidities such ... have raised concerns on the…
This study aimed to determine the effect of diet, an exercise in combination with Orlistat on weight and BMI of the obese patients. Materials and methods: In this prospective observational ... study, we studied the…
directly test gastrointestinal and/or dissolution samples to determine lipase activity and inhibition by Orlistat. Methods: Enzyme assays were performed with porcine pancreatic lipase and para-Nitrophenyl Palmitate…
Context Orlistat is a pancreatic lipase inhibitor licensed for the treatment of obesity. As obesity rates increase and non-prescription dispensing of orlistat increases, an awareness of its adverse effects ... crucial…
present study was aimed at the formulation of immediate release Orlistat. The therapy with these drugs offers a good quality of life for patients who are suffering from obesity ... study: The main objective of this work…
purpose of the research was to prepare Orlistat niosomes from proniosome to improve its poor and variable oral bioavailability. The non-ionic surfactant vesicles are prepared by the reverse phase ... room temperature…
linear, sensitive and specific reverse phase HPLC method was developed and validated to quantify Orlistat in canola oil. Method was developed by using different solvents of different ratios with temperature…
improve diet and decrease inactivity have been developed and extensively studied, mainly in adults. Orlistat is a lipase inhibitor that reduces dietary fat absorption by a third ... goal of this article is to review the…
been treated for six months with a combined treatment of weight loss with Orlistat in the recommended dose, aerobic exercise and muscle mass strengthening, were retrospectively reviewed. Knee Osteoarthritis symptoms
obesity genes play a major role in the central regulation of energy balance. Orlistat (Xenical, Alli) is a synthetic anti-obesity drug approved by European Medicines Association (EMA) and Food ... drug administration…
various studies which demonstrate a reduction in weight, the more effective is the Orlistat at a rate of 30% in the prevention of absorption of fat ingested at a dose ... verify whether it is really effective use of…
Obesity has become a worldwide health problem. Orlistat, an inhibitor of pancreatic lipase, is currently approved as an anti-obesity drug. However, gastrointestinal side effects caused by Orlistat may limit ... orally…
this literature review, we examined the clinical effect of the anti-obesity drugs orlistat, rimonabant and sibutramine on blood pressure, and if this effect was attributed to a change ... body weight. We found a blood…
five mice were divided into 5 groups namely, negative control, positive control which is orlistat, 1000mg/kg, 1500 mg/kg, and 2000 mg/kg of the crude methanolic extract ... concluded that the methanolic extracts of B…
lipase activity by titrimetric assay. The lipase activity was inhib-ited by lipase inhibitor, Orlistat by 100%, as well as by serine metalloprotease inhibitors, Phenyl me-thyl sulphonyl fluoride ... inhibited by Phenyl…
studies had shown that ES- 31 is highly sensitive to commercial anti obesity drug Orlistat for both serine protease and lipase activity and thus orlistat can be used to inhibit ... action of ES-31. Orlistat binds to the…
groups. HFD induced obese rats were treated with methanolic extract (200 mg/kg) and orlistat (5 mg/kg) orally, besides non-obese control group were treated with normal diet ... triglycerides (TG), leptin and…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.